Clinical Programs
Phase 2
Currently in Design (Will be posted on May 2020)
Drug: IDX-1197
Condition: Selected Solid Tumors
Contact:
Location: United States
Phase 1B / 2A
Drug: IDX-1197
Condition: Solid Tumors
Recruitment Status: Recruiting
Sponsor: Idience Co., Ltd.
Collaborator: IlDong Pharmaceutical Co Ltd
Contact:
Location: Korea, Republic of
Phase 1A
Drug: IDX-1197
Condition: Advanced Solid Tumors
Recruitment Status: Recruiting
Sponsor: National OncoVenture
Collaborator: IlDong Pharmaceutical Co Ltd
Contact:
Location: Korea, Republic of
IDX-1197 Clinical Trials
